Purdue Institute for Cancer Research

During March madness, Purdue is putting a spotlight on pediatric cancer research and the many ways Purdue impacts our communities. Had fun helping with the project. Boiler up! youtube.com/watch?v=u9PIys…

Business of Health reporter Kylie Veleta looks back at the remarkable career of Purdue's Dr. Philip Low. Low founded seven companies based on intellectual property developed at Purdue. youtu.be/pDEmrP1enr8

The world lost Philip Low. Because of his life’s work, cancer will keep losing ground. purdue.link/life-legacy-ph…

Hammering Down 💚 Our game-worn jersey auction is now LIVE! All funds will benefit @PUCancerInst Jersey Link: bidpal.net/sb26hdc #BoilerUp🚂

Learn more about this week's @PurdueResFound featured @AcadofInventors fellow: @PurdueScience distinguished professor Arun Ghosh, a leader in the field of structure-based drug design and discovery. purdue.university/40slslV

For scientist Nathaniel Mabe and #Purdue senior Andrew Kinder, the fight against cancer is personal — and it's one inspired by the life and legacy of Tyler Trent.

Cancer can arise when the machinery that organizes DNA goes wrong. PICR member and @purduepharmacy professor Emily Dykhuizen studies chromatin regulation — the system that controls which genes cells can access — and designs molecules that could help stop cancer from evading immune defenses and spreading. purdue.link/ED-cancer-mach…

🥇#1 research university in Indiana 🔬 Top 10 most innovative U.S. public university 🥼 Top 10 in the U.S. for patents Purdue research is changing the game to take the next giant leap. purdue.university/4s07zYt

Purdue Researchers Identify New Pathway for Treating Aggressive Vascular Cancer purduesci.com/4riLkeY

A brilliant mind, an unyielding spirit of hope, and a true champion of discovery. Phil Low's impact on cancer research cannot be overstated. We are deeply grateful for his extraordinary contributions to the field. His work turned fundamental discoveries into therapies that are saving lives, and his legacy will continue to inspire generations.

Purdue University mourns the loss of Phil Low, drug discovery scholar and decorated innovator, who died Wednesday (March 4) at the age of 78. purdue.university/4aTRYUd

We are profoundly saddened to share the passing of Philip Low, one of the most influential scientists in the history of Purdue cancer research. A pioneering chemist and drug discovery innovator, Low devoted his career to transforming fundamental discoveries into therapies that save lives. His work led to multiple FDA-approved cancer drugs and agents, leaving a lasting legacy in cancer research and patient care. purdue.university/4aTRYUd

Every life touched by cancer matters. @LifeAtPurdue researchers are working to save lives and create breakthroughs. Today, your gift will fuel discoveries that can’t wait. Give now at purdue.university/3ZMT91q.

🔔 Scaling research-driven cancer diagnostics The clinical laboratory of Amplified Sciences, co-founded by @PUCancerInst member V. Jo Davisson, earned CAP (@Pathologists) accreditation, strengthening expansion of its pancreatic cancer risk assay, PanCystPro™.

We invite applications for the following AACR-Lobular Breast Cancer Alliance Invasive Lobular Carcinoma grants: --Research Fellowship: a two-year, $130,000 grant --Innovation and Discovery Grants: a one-year $50,000 grant Apply by April 9: brnw.ch/21x0hVl

Scientists across all @LifeAtPurdue's campuses and academic disciplines continue to advance the research enterprise of the university with 11 newly issued patents. purdue.university/4aPUwBc

A drug first developed at Purdue is moving forward in the fight against glioblastoma. Gibson Oncology + NIH have launched a Phase 2 trial of LMP744 for first-time recurrent glioblastoma. Originally designed at Purdue by a research group led by PICR member emeritus Mark Cushman, the drug targets topo 1 + cMYC. ~40 patients will be enrolled. purdue.link/glioblastoma-t…

CALLING ALL PURDUE RESEARCHERS! During the Purdue AI Research Showcase, IPAI and RCAC will be hosting a poster session, “AI research and applications across Purdue—new models, systems, and interdisciplinary breakthroughs solving real‑world challenges”. rcac.purdue.edu/news/7618

Catalysts accelerate chemical reactions, but they can also accelerate the development of new medicines. Scientists at Purdue University (@LifeAtPurdue) are designing catalysts to tackle tough reactions and manufacture components of drug compounds: purdue.edu/newsroom/2025/…